UP!

News

Ampio Pharmaceuticals, Inc. 4.97% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2018 2018-05-10 0.00 0.27
Q4 2017 2018-03-06 0.00 -0.58
Q3 2017 2017-11-07 0.00 -0.06
Q2 2017 2017-08-09 0.00 -0.04
Q1 2017 2017-05-12 0.00 -0.03
Q4 2016 2017-03-16 0.00 -0.06
Q3 2016 2016-11-08 0.00 -0.07
Q2 2016 2016-08-02 0.00 -0.10
Q1 2016 2016-05-06 0.00 -0.13
Q4 2015 2016-02-26 0.00 -0.14

Ratings

2014-08-22 Downgrade Jefferies Group Buy to Hold $14.00 to $5.00
2014-08-21 Reiterated Rating Aegis Buy
2014-03-17 Reiterated Aegis Capital Buy $15 to $16
2012-09-25 Initiated Aegis Capital Buy $11
1970-01-01
2014-08-22 Downgrade Jefferies Group Buy to Hold $14.00 to $5.00
2014-08-21 Reiterated Rating Aegis Buy
2014-03-17 Reiterated Aegis Capital Buy $15 to $16
2012-09-25 Initiated Aegis Capital Buy $11
1970-01-01

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In AMPE 0 funds of 2183 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
MACALUSO MICHAEL Chief Executive Officer 3.44%  (1786752) AMPE /
Giles Richard B 0.42%  (216093) AMPE /
COELHO PHILIP H 0.20%  (104727) AMPE / CPRX / KOOL /
Stevens David R 0.07%  (35789) AMPE /

Comments